Equities research analysts forecast that Teladoc Health Inc (NYSE:TDOC) will post earnings per share (EPS) of ($0.40) for the current fiscal quarter, Zacks reports. Ten analysts have provided estimates for Teladoc Health’s earnings. The lowest EPS estimate is ($0.43) and the highest is ($0.33). Teladoc Health posted earnings per share of ($0.37) in the same quarter last year, which indicates a negative year-over-year growth rate of 8.1%. The company is scheduled to report its next quarterly earnings results on Wednesday, August 7th.
On average, analysts expect that Teladoc Health will report full-year earnings of ($1.53) per share for the current fiscal year, with EPS estimates ranging from ($1.61) to ($1.30). For the next financial year, analysts forecast that the business will post earnings of ($1.10) per share, with EPS estimates ranging from ($1.47) to ($0.83). Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow Teladoc Health.
Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 27th. The health services provider reported ($0.35) EPS for the quarter, meeting analysts’ consensus estimates of ($0.35). The company had revenue of $122.74 million during the quarter, compared to analysts’ expectations of $120.19 million. Teladoc Health had a negative return on equity of 10.86% and a negative net margin of 22.63%.
Several research firms have recently issued reports on TDOC. Zacks Investment Research raised Teladoc Health from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd. Craig Hallum reaffirmed a “buy” rating and issued a $70.00 price objective (down from $80.00) on shares of Teladoc Health in a research note on Wednesday, May 1st. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $70.00 price objective on shares of Teladoc Health in a research note on Tuesday, April 30th. Guggenheim began coverage on Teladoc Health in a research note on Wednesday, April 17th. They issued a “buy” rating for the company. Finally, Stephens began coverage on Teladoc Health in a research note on Tuesday, April 16th. They issued an “overweight” rating and a $75.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Teladoc Health currently has an average rating of “Buy” and a consensus price target of $81.00.
TDOC traded down $0.28 during midday trading on Friday, reaching $61.20. The company had a trading volume of 9,882 shares, compared to its average volume of 1,570,858. The company has a quick ratio of 7.54, a current ratio of 7.54 and a debt-to-equity ratio of 0.42. The stock has a market cap of $4.39 billion, a price-to-earnings ratio of -43.16 and a beta of 1.38. Teladoc Health has a 1 year low of $42.08 and a 1 year high of $89.05.
In other news, SVP Andrew Turitz sold 31,960 shares of the stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $55.82, for a total value of $1,784,007.20. Following the sale, the senior vice president now directly owns 13,455 shares in the company, valued at $751,058.10. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Lewis Levy sold 675 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was sold at an average price of $56.80, for a total value of $38,340.00. Following the completion of the sale, the insider now owns 4,805 shares in the company, valued at $272,924. The disclosure for this sale can be found here. Over the last quarter, insiders sold 179,005 shares of company stock worth $10,813,875. Company insiders own 3.95% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TDOC. Enlightenment Research LLC purchased a new position in Teladoc Health during the 4th quarter worth $25,000. Nikko Asset Management Americas Inc. purchased a new position in Teladoc Health during the 4th quarter worth $25,000. Northwestern Mutual Wealth Management Co. purchased a new position in Teladoc Health during the 1st quarter worth $30,000. Tompkins Financial Corp purchased a new position in Teladoc Health during the 1st quarter worth $31,000. Finally, Ffcm LLC purchased a new position in Teladoc Health during the 4th quarter worth $32,000.
About Teladoc Health
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
See Also: Marijuana Stocks Future Looks Bright
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.